Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: A similar post had to be deleted, because leaders were afraid to let you read it

So when will the BoD and other knowledgeable people, like patent attorneys and IEEEs, jump on board for the easy money? Maybe they just don't like easy money or maybe it is still not the right timing because there are to many unknowns that could upset the apple cart??

I have often wondered if the BoD has tried to drive shareholders away to push the share price lower for their entry point somwhere lower than a nickel. Perhaps the shareholder loyalty has frustrated them. They have certainly done their part to lower expectations and keep shareholders in the dark. Tick tock tick tock.

Share
New Message
Please login to post a reply